Susquehanna International Group’s ACELYRIN SLRN Stock Holding History

Susquehanna International Group’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,000	Closed	-$49.4K	–	13628
2025 Q1	$49.4K	Buy	+20,000	New	+$47.6K	﹤0.01%	11869
2024 Q4	–	Sell	-11,400	Closed	-$56.2K	–	13137
2024 Q3	$56.2K	Buy	+11,400	New	+$58.9K	﹤0.01%	11334
2024 Q2	–	Sell	-75,000	Closed	-$506K	–	13134
2024 Q1	$506K	Sell	75,000 -20,500	-21%	-$156K	﹤0.01%	8485
2023 Q4	$712K	Buy	95,500 +71,100	+291%	+$607K	﹤0.01%	7810
2023 Q3	$248K	Buy	24,400 +13,200	+118%	+$280K	﹤0.01%	9766
2023 Q2	$234K	Buy	+11,200	New	+$229K	﹤0.01%	9953

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's SLRN Position: Q2 2025 in Review

Susquehanna International Group sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 90,669 shares — an estimated $224K sold.

Susquehanna International Group first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $1.04M in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Susquehanna International Group reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Susquehanna International Group sold 90,669 ACELYRIN shares in Q2 2025, an estimated $224K.
Susquehanna International Group first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
Susquehanna International Group's ACELYRIN position peaked at $1.04M in Q2 2023.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.